all-oral treatments for rifampin-resistant tuberculosis. We conducted a phase 3, multinational, open-label, randomized, controlled noninferiority trial to compare standard therapy for treatment of ...

Scientists have discovered three powerful new drug regimens that offer more effective treatment for tuberculosis—bringing ...

Three all-oral shortened regimens have noninferior efficacy compared with standard therapy for fluoroquinolone-suscep ...

At least a handful of patients have developed active TB after receiving cancer treatment designed to boost the immune system’s antitumor response. Ashley started at The Scientist in 2018. Before ...

Tuberculosis is prevalent in the US, but it's both preventable and curable. Early detection and treatment plans have helped limit further disease transmission in the US. However, we've seen ...

The goal was to improve treatment for patients with tuberculosis resistant to rifampin. The WHO estimates that some 410,000 people become sick with rifampin-resistant TB each year, including people ...

Emerging drug-resistant strains are posing significant challenges to the global fight against tuberculosis (TB) and it is a critical task to detect treatment failure as early as possible.

The treatment is very costly for both families and health services. In September 2024, the World Health Organization issued new guidelines for MDR-TB preventive therapy. The guidelines were based ...